These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7769049)

  • 41. Assessment of the oestrogenic activity of the contraceptive progestin levonorgestrel and its non-phenolic metabolites.
    Santillán R; Pérez-Palacios G; Reyes M; Damián-Matsumura P; García GA; Grillasca I; Lemus AE
    Eur J Pharmacol; 2001 Sep; 427(2):167-74. PubMed ID: 11557270
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Morphometric, immunohistological and three-dimensional evaluation of the endometrium of menopausal women treated by oestrogen and Crinone, a new slow-release vaginal progesterone.
    Casanas-Roux F; Nisolle M; Marbaix E; Smets M; Bassil S; Donnez J
    Hum Reprod; 1996 Feb; 11(2):357-63. PubMed ID: 8671224
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Progesterone regulation of endometrial estrogen receptor and cell proliferation during the late proliferative and secretory phase in artificial menstrual cycles in the rhesus monkey.
    Okulicz WC; Balsamo M; Tast J
    Biol Reprod; 1993 Jul; 49(1):24-32. PubMed ID: 8353187
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interactions between oestradiol and epidermal growth factor in endometrial stromal proliferation and differentiation.
    Mellor SJ; Thomas EJ
    J Reprod Fertil; 1995 May; 104(1):157-64. PubMed ID: 7636797
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Measurement of markers for breast cancer in a model system using laser scanning cytometry.
    Zabaglo L; Ormerod MG; Dowsett M
    Cytometry; 2000 Nov; 41(3):166-71. PubMed ID: 11042612
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of the estradiol-mediated endometrial gland formation by the antigestagen onapristone in rabbits: relationship to uterine estrogen receptors.
    Chwalisz K; Hegele-Hartung C; Fritzemeier KH; Beier HM; Elger W
    Endocrinology; 1991 Jul; 129(1):312-22. PubMed ID: 2055191
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ICI 182,780 (Fulvestrant)--the first oestrogen receptor down-regulator--current clinical data.
    Robertson JF
    Br J Cancer; 2001 Nov; 85 Suppl 2(Suppl 2):11-4. PubMed ID: 11900210
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancer.
    Howell A; DeFriend DJ; Robertson JF; Blamey RW; Anderson L; Anderson E; Sutcliffe FA; Walton P
    Br J Cancer; 1996 Jul; 74(2):300-8. PubMed ID: 8688341
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.
    Hosoda M; Yamamoto M; Nakano K; Hatanaka KC; Takakuwa E; Hatanaka Y; Matsuno Y; Yamashita H
    Breast Cancer Res Treat; 2014 Apr; 144(2):249-61. PubMed ID: 24549642
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potential regulation of membrane trafficking by estrogen receptor alpha via induction of rab11 in uterine glands during implantation.
    Chen D; Ganapathy P; Zhu LJ; Xu X; Li Q; Bagchi IC; Bagchi MK
    Mol Endocrinol; 1999 Jun; 13(6):993-1004. PubMed ID: 10379897
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ICI 182,780 inhibits endogenous estrogen-dependent rat uterine growth and tamoxifen-induced developmental toxicity.
    Branham WS; Fishman R; Streck RD; Medlock KL; De George JJ; Sheehan DM
    Biol Reprod; 1996 Jan; 54(1):160-7. PubMed ID: 8838013
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
    Brünner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R
    Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biological effects of fulvestrant on estrogen receptor positive human breast cancer: short, medium and long-term effects based on sequential biopsies.
    Agrawal A; Robertson JF; Cheung KL; Gutteridge E; Ellis IO; Nicholson RI; Gee JM
    Int J Cancer; 2016 Jan; 138(1):146-59. PubMed ID: 26178788
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biochemical studies on endometrium from postmenopausal women receiving hormone replacement therapy.
    King RJ; Whitehead MI; Campbell S; Minardi J
    Postgrad Med J; 1978; 54 Suppl 2():65-8. PubMed ID: 216982
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The potential for a novel pure anti-oestrogen.
    Wakeling AE
    Horm Res; 1989; 32 Suppl 1():257-9; discussion 260. PubMed ID: 2613211
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Physiological and pharmacological regulation of sex steroid receptors in the endometrium (author's transl)].
    Bayard F
    Ann Endocrinol (Paris); 1981; 42(4-5):321-6. PubMed ID: 7340693
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An oestrogen membrane receptor participates in estradiol actions for the prevention of amyloid-beta peptide1-40-induced toxicity in septal-derived cholinergic SN56 cells.
    Marin R; Guerra B; Morales A; Díaz M; Alonso R
    J Neurochem; 2003 Jun; 85(5):1180-9. PubMed ID: 12753077
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Total estradiol and progesterone receptor levels and DNA concentrations in human endometrium with nonuniform postovulatory delay of maturation.
    Gorodeski IG; Sigal A; Lunenfeld B; Beery R; Geier A; Bahari CM
    Isr J Med Sci; 1987 Dec; 23(12):1198-204. PubMed ID: 3440742
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
    Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF
    Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regulation of estrogen and progestin receptor concentrations in an experimental rat prostatic carcinoma by estrogen, antiestrogen, and progesterone.
    Mobbs BG; Johnson IE; DeSombre ER; Toth J; Hughes A
    Cancer Res; 1987 May; 47(10):2645-51. PubMed ID: 3552202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.